Lilly completes Verve Therapeutics acquisition for cardiovascular treatments
Tweet Send to a Friend
Eli Lilly and Company (NYSE: LLY) completed its acquisition of Verve Therapeutics, Inc. (NASDAQ: VERV) on July 25, according to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
